Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations

R Rosenquist^{1

2}, P Ghia³, A Hadzidimitriou⁴, L-A Sutton^{1

2}, A Agathangelidis³, P Baliakas¹, N Darzentas⁵, V Giudicelli⁶, M-P Lefranc⁶, A W Langerak⁷, C Belessi⁸, F Davi⁹, K Stamatopoulos^{1

4}

Affiliations

¹ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
² Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³ Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
⁴ Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
⁵ CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
⁶ IMGT, The International ImMunoGeneTics information system, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UMR CNRS 9002, Université de Montpellier, Montpellier, France.
⁷ Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.
⁸ Department of Hematology, Nikea General Hospital, Athens, Greece.
⁹ Department of Hematology, AP-HP, Hopital Pitié-Salpêtrière, UPMC Univ Paris 06, Paris, France.

Editorial

R Rosenquist et al. Leukemia. 2017 Jul.

. 2017 Jul;31(7):1477-1481.

doi: 10.1038/leu.2017.125. Epub 2017 Apr 25.

¹ Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
² Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
³ Division of Experimental Oncology, IRCCS Istituto Scientifico San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.
⁴ Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece.
⁵ CEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
⁶ IMGT, The International ImMunoGeneTics information system, Laboratoire d'ImmunoGénétique Moléculaire LIGM, Institut de Génétique Humaine IGH, UMR CNRS 9002, Université de Montpellier, Montpellier, France.
⁷ Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, Rotterdam, The Netherlands.
⁸ Department of Hematology, Nikea General Hospital, Athens, Greece.
⁹ Department of Hematology, AP-HP, Hopital Pitié-Salpêtrière, UPMC Univ Paris 06, Paris, France.

No abstract available

Conflict of interest statement

The authors declare no conflict of interest.

1. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102:1515–1525. doi: 10.1172/JCI3009. - DOI - PMC - PubMed
1. Johnson TA, Rassenti LZ, Kipps TJ. Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. J Immunol. 1997;158:235–246. - PubMed
1. Schroeder HW, Jr, Dighiero G. The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. Immunol Today. 1994;15:288–294. doi: 10.1016/0167-5699(94)90009-4. - DOI - PubMed
1. Hashimoto S, Dono M, Wakai M, Allen SL, Lichtman SM, Schulman P. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med. 1995;181:1507–1517. doi: 10.1084/jem.181.4.1507. - DOI - PMC - PubMed
1. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94:1840–1847. - PubMed